Department of Pharmaceuticals Constitutes Committee to Review Pharmaceutical Marketing Practices

Key Highlights:

• The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, constituted a committee.
• The committee's purpose is to review pharmaceutical marketing practices and recommend measures to curb unethical practices.
• Dr. M. Srinivas, Member, NITI Aayog, has been named as the Chairperson of the committee.
• The committee is tasked with submitting its recommendations within two months of its first meeting.
• The Uniform Code for Pharmaceutical Marketing Practices (UCPMP), with its strengthened 2024 version, is currently in operation.

Detailed Insights:

• The committee will undertake a holistic examination of all issues related to unethical pharmaceutical marketing practices.
• It will assess the efficacy of existing mechanisms for monitoring, oversight, and enforcement in the sector.
• Recommendations will aim to strengthen the regulatory framework, ensuring greater transparency, accountability, and effective compliance.
• The move builds upon the UCPMP, which evolved from a voluntary code in 2015 to a more robust, currently operational 2024 version.
• The committee is mandated to consult with concerned stakeholders, technical experts, and institutions during its deliberation process.

Key Concepts Involved:

• Uniform Code for Pharmaceutical Marketing Practices (UCPMP): A code governing ethical marketing practices for pharmaceutical companies in India.
• Department of Pharmaceuticals: A department under the Ministry of Chemicals and Fertilizers, responsible for policy and regulation of the pharmaceutical sector.
• NITI Aayog: The premier policy 'Think Tank' of the Government of India, providing directional and policy inputs.